NVS · NYSE
Novartis AG (NVS) Stock Price & Fundamentals
$486.73−0.38%−$1.84End-of-day price as of Oct 9, 2026
Sample prices
Prices on this page are generated sample data for development, not real market data, so market cap, P/E and dividend yield are illustrative too.
Novartis AG (NVS) closed at $486.73 on Oct 9, 2026, down 0.38% from the previous close of $488.57.
Share price, past year
1Y +21.52%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $486.73 |
| Sep 30, 2026 | $480.02 |
| Aug 31, 2026 | $470.86 |
| Jul 31, 2026 | $483.46 |
| Jun 30, 2026 | $491.08 |
| May 29, 2026 | $516.27 |
| Apr 30, 2026 | $465.04 |
| Mar 31, 2026 | $480.03 |
| Feb 27, 2026 | $466.19 |
| Jan 30, 2026 | $459.22 |
| Dec 31, 2025 | $440.84 |
| Nov 28, 2025 | $418.96 |
| Oct 31, 2025 | $392.94 |
Key statistics
- 52-week range
- $388.14 – $519.92
Financials
Novartis AG reports to the SEC in international accounting standards (IFRS), which Laurel doesn't show yet.
Company profile
- Name
- Novartis AG
- Ticker
- NVS
- Exchange
- NYSE
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- Lichtstrasse 35, Basel, V8 CH 4056
- Incorporated in
- V8
- Fiscal year ends
- December
- SEC CIK
- 0001114448
Frequently asked questions
What is Novartis AG's stock price?
Novartis AG (NVS) closed at $486.73 on Oct 9, 2026, down 0.38% from the previous close of $488.57.
Sources and methodology
Fundamentals come from Novartis AG's filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures